SCHEMBL1413396

SCHEMBL1413396

c1ccc2c(N3CCOCC3)c[nH]c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
KDM4E B2RXH2 3/20 0.53
MAPT P10636 2/20 0.53
THRB P10828 1/20 0.53
LMNA P02545 2/20 0.51
KMT2A Q03164 1/20 0.49
CYP2D6 P10635 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
PDGFRB P09619 1/20 0.46
PRKDC P78527 1/20 0.45
DRD2 P14416 1/20 0.45
PRKCB P05771 1/20 0.44
PRKCA P17252 1/20 0.44
PRKCH P24723 1/20 0.44
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCD Q05655 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26912673 0.94 MAPT (0.59) ALDH1A1KDM4EMAPTTHRBLMNA
SCHEMBL6407264 0.87 LMNA (0.51) ALDH1A1KDM4EMAPTLMNAKMT2A
SCHEMBL2782013 0.84 LMNA (0.51) KDM4EMAPTLMNAKMT2ACYP2D6
SCHEMBL1413377 0.82 HTT (0.54) ALDH1A1KDM4EMAPTLMNAKMT2A
Hydrochloric Acid SCHEMBL11852231 0.81 JAK2 (0.55) KDM4EMAPTLMNAKMT2ACYP2D6
SCHEMBL1442314 0.81 HTR6 (0.63) ALDH1A1KDM4ELMNACYP2D6CYP1A2
SCHEMBL7548171 0.79 BCHE (0.44) KDM4ELMNACYP2D6L3MBTL1DRD2
SCHEMBL1413397 0.79 HTR6 (0.56) KDM4ELMNAL3MBTL1CYP3A4PDGFRB
SCHEMBL9703840 0.78 ADRB1 (0.69) MAPTKMT2ADRD2
SCHEMBL21047718 0.78 BCHE (0.42) ALDH1A1KDM4EMAPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113480466-A Indole substituted amide compound and preparation method and application thereof 厦门大学 2021-10-08 CN disclosed
EP-1699761-B1 CB1 MODULATOR COMPOUNDS LILLY CO ELI (US) 2011-03-16 EP disclosed
EP-1699761-B1 CB1 MODULATOR COMPOUNDS LILLY CO ELI (US) 2011-03-16 EP disclosed
US-7595339-B2 CB1 modulator compounds ELI LILLY AND COMPANY (US) 2009-09-29 US disclosed
US-7595339-B2 CB1 modulator compounds ELI LILLY AND COMPANY (US) 2009-09-29 US disclosed
US-7595339-B2 CB1 modulator compounds ELI LILLY AND COMPANY (US) 2009-09-29 US disclosed
US-20080287504-A1 CB1 MODULATOR COMPOUNDS ALLEN JENNIFER REBECCA 2008-11-20 US disclosed
US-20080287504-A1 CB1 MODULATOR COMPOUNDS ALLEN JENNIFER REBECCA 2008-11-20 US disclosed
US-20080287504-A1 CB1 MODULATOR COMPOUNDS ALLEN JENNIFER REBECCA 2008-11-20 US disclosed
US-7276516-B2 CB1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-10-02 US disclosed
US-7276516-B2 CB1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-10-02 US disclosed
US-7276516-B2 CB1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-10-02 US disclosed
US-20070088018-A1 Cb1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-04-19 US disclosed
US-20070088018-A1 Cb1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-04-19 US disclosed
US-20070088018-A1 Cb1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088018-A1 Cb1 antagonist compounds CNR1, CNR2, CHRNA5 ALDH1A1 3227/4885KDM4E 3185/4885MAPT 542/4885
US-20080287504-A1 CB1 MODULATOR COMPOUNDS CNR1, CNR2, MAG ALDH1A1 3181/4885KDM4E 2897/4885MAPT 548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.